Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Completes $20M Stock Offering

NEW YORK (GenomeWeb) – WaferGen Biosystems announced today that it has completed an offering of common stock and warrants that brought in gross proceeds of $20 million.

The offering comprises 2,000 units priced at $10,000 per unit. Each unit consists of 2,000 shares of common stock and 2,000 warrants to purchase shares of the firm's common stock. In total, 4 million shares of common stock and warrants to purchase 4 million shares were issued in the offering. The warrants have a term of five years and an exercise price of $5 per share.

The offering brought in net proceeds of approximately $18 million. WaferGen said that it intends to use $1.3 million of the funds to repay existing debt, and the rest will be used for general corporate and working capital purposes.

Ladenburg Thalmann & Co. was the sole book-running manager for the offering, while National Securities Corp. and Brean Capital were co-managers on the offering.

Last Friday, when the firm announced the offering, its shares dropped more than 50 percent to close at $4.95. In afternoon trading today, WaferGen shares were up a fraction of 1 percent at $4.60.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.